Presentation

Cost-effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation

Presenter: S. Lee

June 05, 2012

REGISTER for free or LOG IN to view this content

Cost-effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation

Coronary

Factoid

Up Next

Presentation TVT 2012

Case Screening Considerations: Who Should and Shouldn't Have Transfemoral TAVR(2)

Presenter: Jean-Michel Paradis

June 05, 2012

More slides +

Presentation TVT 2012

The Wavecrest: Device Iterations and Clinical Studies

Presenter: Brian Whisenant

June 05, 2012

Presentation TVT 2012

EU Insights on Withholding TAVR in Futile Patients(2)

Presenter: Olaf Wendler

June 05, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.